Recent Quotes (30 days)
You have no recent quotes
| KGC | 5.31 | -0.250-4.50% |  |
| MTG | 6.26 | +0.1402.29% | |
| MS | 27.37 | +0.9103.44% | |
| FRO | 7.87 | +0.0901.16% | |
| 000001 | 3,049.38 | +54.461.82% | |
| NI225 | 16,095.65 | +386.832.46% | |
| HSI | 21,224.74 | +344.241.65% | |
| TAIEX | 8,841.46 | +54.990.63% | |
| UKX | 6,680.69 | -2.17-0.03% | |
| SX5E | 2,933.44 | +48.121.67% | |
| PX1 | 4,331.38 | +66.851.57% | |
| BABA | 81.74 | +0.2800.34% | |
| HUM | 154.71 | +0.7100.46% | |
| SBUX | 57.59 | +1.272.26% | |
| F | 13.45 | +0.1801.36% | |
| AMD | 5.17 | +0.1553.09% | |
| CSCO | 29.61 | +0.1750.59% | |
| RAD | 6.87 | -0.010-0.15% | |
| RF | 8.83 | +0.2603.03% | |
| PBR | 8.08 | +0.3103.99% | |
36.24
+0.09
(0.25%)
After Hours: 36.30
+0.06
(0.17%)
Jul 12, 4:31PM EDT
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 36.03 - 36.30 |
| 52 week | 28.25 - 36.46 |
| Open | 36.15 |
| Vol / Avg. | 16.14M/25.19M |
| Mkt cap | 221.94B |
| P/E | 29.70 |
| Div/yield | 0.30/3.31 |
| EPS | 1.22 |
| Shares | 6.06B |
| Beta | 0.84 |
| Inst. own | 76% |
Events
Aug 2, 2016
Q2 2016 Pfizer Inc Earnings Call
- 10:00AM EDT -
Aug 2, 2016
Q2 2016 Pfizer Inc Earnings Release
- 9:30AM EDT -
Jun 8, 2016
Pfizer Inc Analyst and Investor Call to Review Oncology Business and ASCO Data Presentations
Jun 2, 2016
Pfizer Inc at Sanford C Bernstein Strategic Decisions Conference
May 23, 2016
Pfizer Inc at UBS Global Healthcare Conference
May 3, 2016
Q1 2016 Pfizer Inc Earnings Call
May 3, 2016
Q1 2016 Pfizer Inc Earnings Release
Apr 28, 2016
Pfizer Inc Annual Shareholders Meeting
Apr 22, 2016
Pfizer Inc Annual Shareholders Meeting (Estimated)
|
More events from DailyFinance »
|
Key stats and ratios
| Q2 (Apr '16) | 2015 | |
| Net profit margin | 23.27% | 14.28% |
| Operating margin | 28.98% | 21.14% |
| EBITD margin | - | 38.46% |
| Return on average assets | 7.35% | 4.16% |
| Return on average equity | 18.94% | 10.22% |
| Employees | 97,900 | - |
| CDP Score | - | 90 B |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
About Company - Wikipedia
Volume delayed by 15 mins.
Prices are not from all markets.
Sources include SIX.
Prices are not from all markets.
Sources include SIX.
Advertisement
Description
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. Its portfolio includes medicines, vaccines and medical devices, as well as consumer healthcare products. Its products include Prevnar/Prevenar 13, Lyrica, Enbrel, Lipitor, Viagra, Sutent, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel. Its commercial operations consist of two businesses: Innovative Products business and Established Products business. The Innovative Products business consists of two segments: the Global Innovative Pharmaceutical segment (GIP) and the Global Vaccines, Oncology and Consumer Healthcare segment (VOC). The Established Products business consists of the Global Established Pharmaceutical segment (GEP). Its research focuses on six areas, which include immunology and inflammation, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, and rare diseases.
Officers and directors
| Ian C. Read | Chairman of the Board, Chief Executive Officer | |
| Frank A D'Amelio | Chief Financial Officer, Executive Vice President - Business Operations | |
| Albert Bourla | Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business | |
| Mikael Dolsten M.D., Ph.D. | President - Worldwide Research and Development | |
| John D. Young | Group President - Global Established Pharma Business | |
| Rady A. Johnson II | Executive Vice President, Chief Compliance and Risk Officer | |
| Douglas M. Lankler | Executive Vice President, General Counsel | |
| Charles H. Hill III | Executive Vice President - Worldwide Human Resources | |
| Freda C. Lewis-Hall M.D. | Executive Vice President, Chief Medical Officer | |
| Anthony J. Maddaluna | Executive Vice President, President - Pfizer Global Supply |